X0202 SCHEDULE 13G 0001646799 XXXXXXXX LIVE Common stock, par value $0.001 per share 05/20/2026 0000946644 AIM ImmunoTech Inc. 00901B303 2117 SW Highway 484 Ocala FL 34473 Rule 13d-1(c) Mitchell P. Kopin X1 0.00 0.00 0.00 0.00 0.00 N 0.00 HC IN Daniel B. Asher X1 0.00 0.00 0.00 0.00 0.00 N 0.00 HC IN Intracoastal Capital LLC DE 0.00 0.00 0.00 0.00 0.00 N 0.00 OO AIM ImmunoTech Inc. 2117 SW Highway 484, Ocala, Florida 34473 This Schedule 13G is being filed on behalf of (i) Mitchell P. Kopin, an individual ("Mr. Kopin"), (ii) Daniel B. Asher, an individual ("Mr. Asher") and (iii) Intracoastal Capital LLC, a Delaware limited liability company ("Intracoastal" and together with Mr. Kopin and Mr. Asher, collectively the "Reporting Persons"). The principal business office of Mr. Kopin and Intracoastal is 245 Palm Trail, Delray Beach, Florida 33483. The principal business office of Mr. Asher is 111 W. Jackson Boulevard, Suite 2000, Chicago, Illinois 60604. Mr. Kopin is a citizen of the United States of America. Mr. Asher is a citizen of the United States of America. Intracoastal is a Delaware limited liability company. Y (i) Immediately following the execution of the Securities Purchase Agreement with the Issuer on May 20, 2026 (the "SPA") (as disclosed in the Form 8-K filed by the Issuer with the Securities and Exchange Commission on May 21, 2026), each of the Reporting Persons may have been deemed to have beneficial ownership of 1,538,462 shares of Common Stock to be issued to Intracoastal at the closing of the transaction contemplated by the SPA, and all such shares of Common Stock represent beneficial ownership of approximately 8.5% of the Common Stock, based on (1) 16,505,501 shares of Common Stock outstanding as of May 20, 2026, as reported by the Issuer, plus (2) 1,538,462 shares of Common Stock to be issued to Intracoastal at the closing of the transaction contemplated by the SPA. The foregoing excludes 3,076,924 shares of Common Stock issuable upon exercise of a warrant to be issued to Intracoastal at the closing of the transaction contemplated by the SPA (the "Intracoastal Warrant") because the Intracoastal Warrant is not exercisable until the effective date of stockholder approval of the issuance of the shares of Common Stock issuable upon exercise of the Intracoastal Warrant (and the Intracoastal Warrant also contains a blocker provision under which the holder thereof does not have the right to exercise the Intracoastal Warrant to the extent (but only to the extent) that such exercise would result in beneficial ownership by the holder thereof, together with the holder's affiliates, and any other persons acting as a group together with the holder or any of the holder's affiliates, of more than 4.99% of the Common Stock). Without such blocker provision (and assuming the Intracoastal Warrant was currently exercisable), each of the Reporting Persons may have been deemed to have beneficial ownership of 4,615,386 shares of Common Stock. (ii) As of the close of business on May 27, 2026, each of the Reporting Persons may have been deemed to have beneficial ownership of no shares of Common Stock. The foregoing excludes 3,076,924 shares of Common Stock issuable upon exercise of the Intracoastal Warrant because the Intracoastal Warrant is not exercisable until the effective date of stockholder approval of the issuance of the shares of Common Stock issuable upon exercise of the Intracoastal Warrant (and the Intracoastal Warrant also contains a blocker provision under which the holder thereof does not have the right to exercise the Intracoastal Warrant to the extent (but only to the extent) that such exercise would result in beneficial ownership by the holder thereof, together with the holder's affiliates, and any other persons acting as a group together with the holder or any of the holder's affiliates, of more than 4.99% of the Common Stock). Without such blocker provision (and assuming the Intracoastal Warrant was currently exercisable), each of the Reporting Persons may have been deemed to have beneficial ownership of 3,076,924 shares of Common Stock. 0.00% 0 0 0 0 N Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. Exhibit 1 - Joint Filing Agreement Mitchell P. Kopin /s/ Mitchell P. Kopin 05/27/2026 Daniel B. Asher /s/ Daniel B. Asher 05/27/2026 Intracoastal Capital LLC /s/ Mitchell P. Kopin 05/27/2026